Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2021)
Nu-Med Plus' (NUMD) quarterly Depreciation & Amortization (CF) came in at $2650.0 in Q4 2021, little changed year-over-year from $2650.0 in Q4 2020, and little changed quarter-over-quarter from $2650.0 in Q3 2021.
Powered by 
Analysis
Nu-Med Plus (NUMD) Depreciation & Amortization (CF) (2012 - 2021) Analysis & Trends
Nu-Med Plus has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $2650.0 for Q4 2021.
- In Q4 2021, Depreciation & Amortization (CF) changed 0.0% year-over-year to $2650.0; the TTM figure through Sep 2022 stood at $2650.0 (down 71.7% YoY), while the FY2022 annual figure was $2267.0, down 75.79% from the prior year.
- Depreciation & Amortization (CF) came in at $2650.0 for Q4 2021 at Nu-Med Plus, roughly flat from $2650.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $3803.0 in Q2 2018 to a low of $1416.0 in Q2 2021.
- Average Depreciation & Amortization (CF) over 5 years is $3090.6, with a median of $3091.0 recorded in 2019.
- The largest YoY upside for Depreciation & Amortization (CF) was 119.03% in 2017 against a maximum downside of 79.37% in 2017.
- Over 5 years, Depreciation & Amortization (CF) stood at $3585.0 in 2017, then climbed by 5.27% to $3774.0 in 2018, then retreated by 19.55% to $3036.0 in 2019, then decreased by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $2650.0 in Q4 2021, $2650.0 in Q3 2021, and $1416.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 2,650.00 |
| Sep 30, 2021 | 2,650.00 |
| Jun 30, 2021 | 1,416.00 |
| Mar 31, 2021 | 2,649.00 |
| Dec 31, 2020 | 2,650.00 |
| Sep 30, 2020 | 3,048.00 |
| Jun 30, 2020 | 3,048.00 |
| Mar 31, 2020 | 3,048.00 |
| Dec 31, 2019 | 3,036.00 |
| Sep 30, 2019 | 3,134.00 |
| Jun 30, 2019 | 3,421.00 |
| Mar 31, 2019 | 3,775.00 |
| Dec 31, 2018 | 3,774.00 |
| Sep 30, 2018 | 3,581.00 |
| Jun 30, 2018 | 3,803.00 |
| Mar 31, 2018 | 3,585.00 |
| Dec 31, 2017 | 3,585.00 |
| Sep 30, 2017 | 3,586.00 |
| Jun 30, 2017 | 3,585.00 |
| Mar 31, 2017 | 1,787.00 |